Can Islet Transplantation Possibly Reduce Mortality in Type 1 Diabetes

Islet transplantation (IT) is a successful natural cell therapy. But the benefits are known mostly to individuals with severe type 1 diabetes who undergo IT and the health care professionals that work to make the therapy available, reproducible, and safe. Data linking IT to overall survival in T1D m...

Full description

Saved in:
Bibliographic Details
Main Authors: Jeffrey S. Isenberg, Fouad Kandeel
Format: Article
Language:English
Published: SAGE Publishing 2025-01-01
Series:Cell Transplantation
Online Access:https://doi.org/10.1177/09636897241312801
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832593497084919808
author Jeffrey S. Isenberg
Fouad Kandeel
author_facet Jeffrey S. Isenberg
Fouad Kandeel
author_sort Jeffrey S. Isenberg
collection DOAJ
description Islet transplantation (IT) is a successful natural cell therapy. But the benefits are known mostly to individuals with severe type 1 diabetes who undergo IT and the health care professionals that work to make the therapy available, reproducible, and safe. Data linking IT to overall survival in T1D might alter this situation and frame the therapy in a more positive light. Recent analysis of mortality in several cohorts suggests that IT has possible survival benefits when used alone or in conjunction with renal transplantation. Multi-center prospective studies with long-term follow-up of individuals that receive stand-alone IT versus individuals who qualify for but do not undergo the procedure would seem reasonable to undertake to confirm an IT survival benefit.
format Article
id doaj-art-c2373cb6956d407ca6dc346b995d60bd
institution Kabale University
issn 1555-3892
language English
publishDate 2025-01-01
publisher SAGE Publishing
record_format Article
series Cell Transplantation
spelling doaj-art-c2373cb6956d407ca6dc346b995d60bd2025-01-20T14:03:26ZengSAGE PublishingCell Transplantation1555-38922025-01-013410.1177/09636897241312801Can Islet Transplantation Possibly Reduce Mortality in Type 1 DiabetesJeffrey S. Isenberg0Fouad Kandeel1Department of Diabetes Complications and Metabolism, Arthur Riggs Diabetes & Metabolism Research Institute, Beckman Research Institute, City of Hope National Medical Center, Duarte, CA, USADepartment of Translational Research and Cellular Therapeutics, Arthur Riggs Diabetes & Metabolism Research Institute, Beckman Research Institute, City of Hope National Medical Center, Duarte, CA, USAIslet transplantation (IT) is a successful natural cell therapy. But the benefits are known mostly to individuals with severe type 1 diabetes who undergo IT and the health care professionals that work to make the therapy available, reproducible, and safe. Data linking IT to overall survival in T1D might alter this situation and frame the therapy in a more positive light. Recent analysis of mortality in several cohorts suggests that IT has possible survival benefits when used alone or in conjunction with renal transplantation. Multi-center prospective studies with long-term follow-up of individuals that receive stand-alone IT versus individuals who qualify for but do not undergo the procedure would seem reasonable to undertake to confirm an IT survival benefit.https://doi.org/10.1177/09636897241312801
spellingShingle Jeffrey S. Isenberg
Fouad Kandeel
Can Islet Transplantation Possibly Reduce Mortality in Type 1 Diabetes
Cell Transplantation
title Can Islet Transplantation Possibly Reduce Mortality in Type 1 Diabetes
title_full Can Islet Transplantation Possibly Reduce Mortality in Type 1 Diabetes
title_fullStr Can Islet Transplantation Possibly Reduce Mortality in Type 1 Diabetes
title_full_unstemmed Can Islet Transplantation Possibly Reduce Mortality in Type 1 Diabetes
title_short Can Islet Transplantation Possibly Reduce Mortality in Type 1 Diabetes
title_sort can islet transplantation possibly reduce mortality in type 1 diabetes
url https://doi.org/10.1177/09636897241312801
work_keys_str_mv AT jeffreysisenberg canislettransplantationpossiblyreducemortalityintype1diabetes
AT fouadkandeel canislettransplantationpossiblyreducemortalityintype1diabetes